Case Name: In re Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation
Case Number: 1:23-cv-00818
Court: U.S. District Court for the Northern District of Illinois
Role: Co-Lead Counsel
Status: Ongoing

In re Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

Hair Relaxers Causing Cancer

DiCello Levitt leads the nationwide lawsuit seeking justice for women harmed by cancer-causing chemicals in hair straighteners.

Billions of dollars in damages are at stake as manufacturers of toxic hair relaxers face growing legal pressure.

For decades, beauty products marketed primarily to Black women contained harmful chemicals with known links to hormone-sensitive cancers. DiCello Levitt is leading nationwide litigation to hold the companies behind these products accountable for the widespread harm they’ve caused.

What’s the Risk?

Hair relaxers and chemical straighteners contain endocrine-disrupting chemicals (EDCs) that interfere with the body’s hormone systems. These products, often used from early childhood through adulthood, have been linked to significantly increased risks of uterine and breast cancer, particularly among Black women.

Uterine Cancer

Recent studies show that frequent users of chemical hair straighteners are more than twice as likely to develop uterine cancer compared to non-users. Black women, who make up the majority of hair relaxer users, are disproportionately affected; they are twice as likely to be diagnosed with uterine cancer and often face worse outcomes due to delayed diagnosis and treatment.

Our Role in the Litigation

DiCello Levitt serves as Plaintiffs’ Co-Lead Counsel representing thousands of women diagnosed with uterine cancer after using these products. We are demanding billions in compensation from the manufacturers that knowingly exposed consumers to dangerous chemicals.

This case is In re Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation. The DiCello Levitt team is led by Diandra “Fu” Debrosse and includes Mark DiCello, Adam Levitt, Mark Abramowitz, John Tangren.

For updates on this case and other major cases, join our mailing list.